Abstract Library

#4071 Hospital record data on the clinical presentation and diagnostic investigations of small intestinal neuroendocrine tumors (SI-NETs)

Introduction: The diagnosis of small intestinal neuroendocrine tumors(SI-NETs) is often delayed due to non-specific symptoms, difficulty imaging, and lack of awareness.

Conference:

Presenting Author: Gould H

Authors: Gould H, Kapish A, Karategos T, Abbas S, Olive S,

Keywords: small intestinal neuroendocrine tumor, investigation, Colonoscopy, CT, presentation, symptoms, Diagnosis,

#3642 GP-patient interactions and coding of neuroendocrine tumors (NETs) in primary care records

Introduction: Diagnostic delays in NETs are common with improved diagnosis times recently shown in Wales. Although studies have explored GP visits, these are based on patient surveys with recall bias and no exploration of GP coded data.

Conference:

Presenting Author: Olive S

Authors: Olive S, Gould H, Navaratnam J, Khan M,

Keywords: diagnosis, GP, primary care, coding,

#3448 Differential diagnosis of diarrhoea in patients with neuroendocrine tumors

Introduction: Patients with neuroendocrine tumors (NETs) frequently experience diarrhoea that can impact their quality of life. Pancreatic enzyme insufficiency (PEI), bile acid diarrhoea (BAD) and small intestinal bacterial overgrowth (SIBO) are potential causes. There is a limited data on prevalence of these conditions in NETs.

Conference:

Presenting Author: Navaratnam J

Authors: Navaratnam J, Reed H, Sivananthan M, Rela A, Khan M,

Keywords: Neuroendocrine, Research, Diarrhoea, Quality of LIfe,

#3444 Earlier diagnosis of Neuroendocrine Tumors (NETs) through transformation of the South Wales NET Service

Introduction: Neuroendocrine tumors (NETs) are heterogeneous cancers, arising mainly from the gastroenteropancreatic tract. Delayed diagnosis and mislabelling are widely recognised internationally in midgut NETs with little data describing how to improve diagnosis times. In 2017, transformation of the South Wales NET Service included a change to a gastroenterology-led service model, alongside education and forming working relationships with gastroenterologists and surgeons.

Conference:

Presenting Author:

Authors: Gould H, Kapish A, Karategos T, Abbas S, Taylor R,

Keywords: midgut NET, midgut neuroendocrine tumor, diagnosis, diagnostic delay, investigation, mislabel, imaging,

#3410 Quality of life and gastrointestinal symptoms according to phase of disease in patients with NETs

Introduction: The focus of management in neuroendocrine tumors (NETS) is to control tumor progression and to maintain health-related quality of life (HRQoL). The EORTC QLQ-GINET.21 has been validated to assess HRQoL in NETs although with limited data in different phases of disease. The Gastrointestinal symptom rating scale (GSRS) has been used in functional gut disorders but given the predominance of gastrointestinal symptoms in NET patients it may be a useful tool in this population.

Conference:

Presenting Author: Rela A

Authors: Rela A, Navaratnam J, Khan M,

Keywords: neuroendocrine, research, quality of life, GINET.21, GSRS,